Related Articles
HSCT for Severe Autoimmune Diseases
Despite the innovations of new biologics and disease-modifying anti-rheumatic drugs, a large unmet need remains for patients with rheumatic autoimmune disease. Treatment remains limited for many conditions, including for conditions with a dim prognosis, such as systemic sclerosis.1 One promising treatment avenue is hematopoietic stem-cell transplantation (HSCT). Here, we provide background on HSCT for severe…
Cellular Therapy of Autoimmune Disease
Is a novel treatment breakthrough on the horizon?
Progress Continues in Systemic Sclerosis
Advances in genetics and potential therapies shed new light on the disease
Basics of Biologic Joint Reconstruction
For young patients especially, this can delay knee replacement and provide better outcomes.